Brief: Intelligent Bio Solutions Achieves 94.1% Accuracy In Method Comparison Study
26/11/2024 13:43
Nov 26 (Reuters) - Intelligent Bio Solutions Inc
INBS.O :
* INTELLIGENT BIO SOLUTIONS ACHIEVES 94.1% ACCURACY IN
METHOD
COMPARISON STUDY, FOLLOWING POSITIVE PK STUDY RESULTS
* INTELLIGENT BIO SOLUTIONS: FINGERPRINTING DRUG SCREENING
SYSTEM
ON PATH TO FDA 510(K) SUBMISSION, EXPECTED IN FOURTH CALENDAR
QUARTER OF 2024
Source text: ID:nGNX24nyQD
Further company coverage: INBS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelligent Bio Solutions
See all newsBrief: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study